Natalizumab and the development of extensive brain lesions in neuromyelitis optica.

Authors	Maciej Juryńczyk, Krzysztof Zaleski, Krzysztof Selmaj
Journal	Journal of neurology (J Neurol) Vol. 260 Issue 7 Pg. 1919-21 (Jul 2013) ISSN: 1432-1459 [Electronic] Germany
PMID	23719787 (Publication Type: Case Reports, Letter)
Chemical References	Antibodies, Monoclonal, Humanized Natalizumab
Topics	Adult Antibodies, Monoclonal, Humanized (adverse effects, therapeutic use) Brain (drug effects, pathology) Brain Diseases (chemically induced, pathology) Female Humans Natalizumab Neuromyelitis Optica (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!